Publications by authors named "Francesca Primi"

Claim this Profile
A
A phase II study of nivolumab plus metformin in pre-treated metastatic renal cell carcinoma patients: NivoMet TWINS-GU002 Study.
Chiara Ciccarese, Daniela Arduini, Francesca Primi, Ileana Sparagna, Alessandro Strusi

Tumori· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous Thromboembolic Risk Does Not Increase After a Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine in Cancer Patients Receiving Active Systemic Therapies: Updated Results from the Vax-On-Third-Profile Study.
Fabrizio Nelli, Enzo Maria Ruggeri, Antonella Virtuoso, Diana Giannarelli, Jona Barbuta, Francesca Primi

Vaccines (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study.
Roberto Iacovelli, Chiara Ciccarese, Sebastiano Buti, Paolo Andrea Zucali, Emanuela Fantinel, Francesca Primi

Eur Urol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Herpes zoster after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: a prospective study.
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Eleonora Marrucci, Francesca Primi

Clin Exp Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related adverse events and disease outcomes after the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients receiving immune checkpoint inhibitors.
Fabrizio Nelli, Diana Giannarelli, Agnese Fabbri, Antonella Virtuoso, Julio Rodrigo Giron Berrios, Francesca Primi

Cancer Immunol Immunother· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Peripheral Immune Cells after the Third Dose of SARS-CoV-2 mRNA-BNT162b2 Vaccine and Disease Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Prospective Analysis of the Vax-on-Third-Profile Study.
Fabrizio Nelli, Carlo Signorelli, Agnese Fabbri, Diana Giannarelli, Antonella Virtuoso, Francesca Primi

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Antibody Response after Booster Vaccination on SARS-CoV-2 Breakthrough Infections and Disease Outcomes in Advanced Cancer Patients: A Prospective Analysis of the Vax-on-Third Study.
Fabrizio Nelli, Agnese Fabbri, Antonella Virtuoso, Diana Giannarelli, Julio Rodrigo Giron Berrios, Francesca Primi

Curr Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients.
Enzo Maria Ruggeri, Fabrizio Nelli, Diana Giannarelli, Agnese Fabbri, Julio Rodrigo Giron Berrios, Francesca Primi

Sci Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Experience of the Prognostic Significance of the Primary Tumor Location on the Timing of Colorectal Liver Metastases: A Retrospective Analysis.
Carlo Signorelli, Pietro Maria Amodio, Mario Giovanni Chilelli, Roberto Santoro, Marta Schirripa, Francesca Primi

Cureus· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral lymphocyte subset counts predict antibody response after SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients: Results from the Vax-On-Profile study.
Fabrizio Nelli, Agnese Fabbri, Valentina Panichi, Diana Giannarelli, Giuseppe Topini, Francesca Primi

Int Immunopharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Nivolumab and Metformin in Diabetic Cancer Patients: Is It Safe and More Active?
Chiara Ciccarese, Roberto Iacovelli, Sebastiano Buti, Francesca Primi, Serena Astore

Anticancer Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune-related Thyroid Dysfunction (irTD) in Non-small Cell Lung Cancer (NSCLC) Correlates With Response and Survival.
Mario Giovanni Chilelli, Carlo Signorelli, Julio Rodrigo Giron Berrios, Angelo Onorato, Fabrizio Nelli, Francesca Primi

Cancer Diagn Progn· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solitary fibrous tumor/hemangiopericytoma of the penis: Report of the first case.
Daniele Castellani, Giancarlo Sebastiani, Simone Maurelli, Alessandro Andrisano, Luigi Mazzone, Francesca Primi

Urologia· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin receptor scintigraphy in metastatic breast cancer patients.
Silvia Mezi, Francesca Primi, Errico Orsi, Francesca Capoccetti, Francesco Scopinaro

Oncol Rep· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
Silvia Mezi, Francesca Primi, Francesca Capoccetti, Francesco Scopinaro, Mauro Modesti

Int J Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis